Should glucose-sparing prescriptions be expected to reduce the cardiovascular risk of peritoneal dialysis patients?
J Am Soc Nephrol
.
2013 Nov;24(11):1713-6.
doi: 10.1681/ASN.2013080823.
Epub 2013 Aug 29.
Authors
Rajnish Mehrotra
1
,
Ian H de Boer
Affiliation
1
Kidney Research Institute and Division of Nephrology, University of Washington, Seattle, Washington.
PMID:
23990676
PMCID:
PMC3810097
DOI:
10.1681/ASN.2013080823
No abstract available
Publication types
Editorial
Comment
MeSH terms
Diabetic Nephropathies / therapy*
Female
Glucose / administration & dosage*
Humans
Male
Peritoneal Dialysis / methods*
Substances
Glucose